$NVS Income Statement | Understand Stock

$NVS

$153.81 +$2.69 (1.78%) Close

Financial Statements

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Net sales to third parties from continuing operations
Sales to discontinued segment
Net sales from continuing operations
Other revenues
Cost of goods sold
Gross profit from continuing operations
Selling, general and administration
Research and development
Other income
Other expense
Operating income from continuing operations
Loss from associated companies
Interest expense
Other financial income and expense
Income before taxes from continuing operations
Income taxes
Net income from continuing operations
Net income from discontinued operations before gain on distribution
Net income from discontinued operations
Net income
Attributable to
Shareholders of Novartis AG
Non-controlling interests
Basic earnings per share [abstract]
Basic earnings per share, Continuing operations
Basic earnings per share, Discontinued operations
Basic earnings per share
Diluted earnings per share [abstract]
Diluted earnings per share, Continuing operations
Diluted earnings per share, Discontinued operations
Diluted earnings per share

Comments